News
84. 4% of Cancer Patients Taking Ivermectin + Mebendazole Reported No Evidence of Disease, Tumor Regression, or Cancer Stabilization After 6 Months
1+ mon, 1+ week ago (302+ words) I joined Steve Gruber on Real America's Voice to break down what is now the largest real-world human analysis of ivermectin and mebendazole in cancer patients. 84. 4% of the cancer patients taking ivermectin + mebendazole reported no evidence of disease, tumor regression,…...
Symbols: lse:azn